Revenue Jump Fueled by Price Hikes

Cera Sanitaryware (CRS) reported strong double-digit revenue growth for the fourth quarter of fiscal year 2026. The company significantly increased prices, with hikes averaging about 12% in sanitaryware and 16% for faucetware during the quarter.

Margins Squeeze Despite Growth

However, Cera Sanitaryware's EBITDA margin declined. This was due to higher trade discounts offered to distributors and rising costs for key raw materials, especially brass. The company aims for margin stabilization between 14% and 15% in fiscal year 2027, expecting this to be achievable through sustained pricing power and cost efficiencies. On May 11, 2026, the stock opened at ₹7,150 with trading volumes 1.5 times the daily average, showing investor interest following the results.

Valuation and Analyst Debate

Investors are weighing Cera Sanitaryware's performance against its high valuation. As of May 2026, the company's trailing twelve-month P/E ratio was around 48x, and its market capitalization was near ₹15,500 Crore. This valuation is higher than some peers like HSIL (around 35x P/E) but comparable to Somany Ceramics (around 42x P/E), while Kajaria Ceramics trades higher at about 55x P/E. The building materials sector generally remains strong, supported by urbanization and government housing initiatives, but raw material cost inflation is an industry-wide issue. Cera Sanitaryware saw a notable stock dip in May 2025 when similar margin concerns arose, though it later recovered. Analysts are debating whether the company's reliance on price increases to boost margins is sustainable long-term, especially with ongoing cost pressures. The company's financial leverage and dependence on materials like brass also add to volatility compared to competitors with broader revenue bases or greater scale. Any slowdown in real estate or rise in interest rates could affect demand and pressure margins further.

Analyst Sees Continued Growth

Despite concerns, Prabhudas Lilladher maintains a 'BUY' rating for Cera Sanitaryware, setting a price target of ₹7,429. The brokerage projects revenue and EBITDA compound annual growth rates (CAGRs) of 16.3% and 20.9% respectively from FY26 to FY28. It forecasts 18-20% revenue growth for FY27, driven by its sanitaryware, faucetware, Senator, and Polypluz brands.